Article

Low, high IOPs should be carefully monitored immediately following phaco

Washington, DC &#8212 Patients who do not have glaucoma and those with glaucoma should be carefully monitored in the immediate postoperative period following phacoemulsification and at postoperative day 1 for low and high IOPs, according to Bradford J. Shingleton, MD.

April 18 - Washington, DC - Patients who do not have glaucoma and those with glaucoma should be carefully monitored in the immediate postoperative period following phacoemulsification and at postoperative day 1 for low and high IOPs, according to Bradford J. Shingleton, MD.

It has been reported in the literature in 2001 that hypotony with an IOP of less than or equal to 5 mm Hg can occur within the first 30 minutes after the cataract procedure in eyes that exhibit no signs of problems, such as shallow chambers, wound leaks, or endophthalmitis. These eyes had undergone uncomplicated phacoemulsification with topical anesthesia.

Dr. Shingleton expanded on this study to evaluate the incidence of early hypotony and then IOP spikes on the first postoperative day in a large group of normal and glaucoma eyes (315 eyes total) that also underwent uncomplicated phaco. The difference in the study was the eyes had all been treated with peribulbar anesthesia.

He found the mean postoperative pressure was 15 mm Hg and at 30 minutes, dropped to a mean of 13 mm Hg (range, 2 to 42 mm Hg).

"There was only a 6.4% incidence of IOP less than or equal to 5 mm Hg at 30 minutes after phaco," Dr. Shingleton said. There was no significant difference between normal eyes and those with glaucoma. Six of 315 eyes experienced hypotony 30 minutes after the procedure and there was no hypotony on day 1.

In the normal eyes at postoperative day 1, the mean pressure was 18.5 mm Hg and 11 of 240 eyes had greater than 30 mm Hg, he said.

However, on postoperative day 1, eyes with glaucoma were at increased risk of pressures greater than 30 mm Hg, he said.

"We had 9/30 eyes with greater than 30 mm Hg. So 30% of open-angle glaucoma eyes had an IOP on postoperative day 1 greater than 30 mm Hg," Dr. Shingleton said. "This is very important. It may have significant impact for eyes with compromised optic nerves."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.